-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
- X4 Pharmaceuticals, Inc Operating Lease, Payments for the quarter ending June 30, 2024 was $343K, a 0.58% decline year-over-year.
- X4 Pharmaceuticals, Inc Operating Lease, Payments for the twelve months ending June 30, 2024 was $1.38M, a 1.17% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2023 was $1.39M, a 2.29% increase from 2022.
- X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2022 was $1.35M, a 7.72% increase from 2021.
- X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2021 was $1.26M, a 67.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)